Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityNo recent work listed

Leizhen Zheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1309-3755; OpenAlex author ID A5101997469. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
40
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper

Papers 5

  1. Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer. Co-author DOI 10.1016/j.jncc.2022.08.006↗
  2. A Retrospective Case Series Of High-Intensity Focused Ultrasound (HIFU) In Combination With Gemcitabine And Oxaliplatin (Gemox) On Treating Elderly Middle And … Last author DOI 10.2147/ott.s220299↗
  3. Prognostic role of HER2 amplification based on fluorescence in situ hybridization (FISH) in pancreatic ductal adenocarcinoma (PDAC): a meta-analysis. Last author DOI 10.1186/s12957-016-0792-x↗
  4. Prognostic value of cancer stem cell marker CD133 expression in pancreatic ductal adenocarcinoma (PDAC): a systematic review and meta-analysis. Last author PMID 26722393↗
  5. ZIP4 is a novel diagnostic and prognostic marker in human pancreatic cancer: a systemic comparison between EUS-FNA and surgical specimens. Co-author DOI 10.2174/1566524013666131217112921↗

Closest collaborators

The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaoping Li · 2 shared papers, 2015–2016 · strength 0.16
  2. Shuangfen Tao · 1 shared paper, 2019 · strength 0.11
  3. Feng Jiao · 1 shared paper, 2022 · strength 0.09
  4. Zheng Wang · 1 shared paper, 2022 · strength 0.09
  5. Zhiwei Li · 1 shared paper, 2022 · strength 0.09
  6. Tao Zhang · 1 shared paper, 2022 · strength 0.09
  7. Qingyong Ma · 1 shared paper, 2022 · strength 0.09
  8. Liwei Wang · 1 shared paper, 2022 · strength 0.09
  9. Chunyi Hao · 1 shared paper, 2022 · strength 0.09
  10. Gang Ren · 1 shared paper, 2022 · strength 0.09
  11. Jie Chen · 1 shared paper, 2022 · strength 0.09
  12. Dan Cao · 1 shared paper, 2022 · strength 0.09
  13. Jian Wang · 1 shared paper, 2022 · strength 0.09
  14. Yongrui Bai · 1 shared paper, 2022 · strength 0.09
  15. Zhihong Zhang · 1 shared paper, 2022 · strength 0.09
  16. Yongwei Sun · 1 shared paper, 2022 · strength 0.09
  17. Ji Li · 1 shared paper, 2022 · strength 0.09
  18. Jianping Xiong · 1 shared paper, 2022 · strength 0.09
  19. Jun Zhou · 1 shared paper, 2022 · strength 0.09
  20. Feng‐Hua Wang · 1 shared paper, 2022 · strength 0.09
  21. Da Li · 1 shared paper, 2022 · strength 0.09
  22. Chengfeng Wang · 1 shared paper, 2022 · strength 0.09
  23. Xianbao Zhan · 1 shared paper, 2022 · strength 0.09
  24. Enxiao Li · 1 shared paper, 2022 · strength 0.09
  25. Jihui Hao · 1 shared paper, 2022 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.